Physician profile
James Christopher Grant
NPI 1619959939
$3,230.84
in general payments reported to CMS, 2019-2025
15 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $93.96 · 2021: $163 · 2022: $385 · 2023: $240 · 2024: $294 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216 · Travel and Lodging: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.32 |
| Travel and Lodging | $889.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,177.36 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Aerin Medical INC. | $486.30 | 2019-2025 | |
| Glaxosmithkline, LLC. | $273.95 | 2022-2023 | Nucala |
| Intersect Ent, INC. | $261.63 | 2019-2021 | |
| Medtronic, INC. | $180.24 | 2023-2025 | Propel, Swiftset, Stealthstation S8 Platform |
| Stryker Corporation | $172.22 | 2019-2022 | |
| Hologic Sales and Service, LLC | $148.38 | 2024 | Coolseal Generator |
| Medtronic USA, INC. | $118.53 | 2019 | |
| Optinose US, INC. | $109.54 | 2019-2025 | |
| Acclarent, INC | $84.08 | 2019-2022 | |
| Olympus America INC. | $82.68 | 2019 | |
| Neurent Medical Limited | $77.19 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Novartis Pharmaceuticals Corporation | $20.06 | 2019 | |
| Inspire Medical Systems, INC. | $19.81 | 2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $18.87 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.